Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.
TOKYO (Reuters) - Japan's Astellas Pharma <4503.T> loses U.S. patent protection on Prograf, a major transplant drug, on Tuesday, amid worries that its market share may erode more quickly than expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results